Inventory Summary of Emmaus Life Sciences, Inc.

Emmaus Life Sciences, Inc.'s latest annual inventory in 2023 was 1.71 Million USD , down -28.08% from previous year.
Emmaus Life Sciences, Inc.'s latest quarterly inventory in 2024 Q2 was 1.62 Million USD , up 6.61% from previous quarter.
Emmaus Life Sciences, Inc. reported annual inventory of 2.37 Million USD in 2022, down -45.83% from previous year.
Emmaus Life Sciences, Inc. reported annual inventory of 4.39 Million USD in 2021, down -38.03% from previous year.
Emmaus Life Sciences, Inc. reported quarterly inventory of 1.52 Million USD for 2024 Q1, down -10.75% from previous quarter.
Emmaus Life Sciences, Inc. reported quarterly inventory of 1.65 Million USD for 2023 Q3, down -9.04% from previous quarter.

Annual Inventory Chart of Emmaus Life Sciences, Inc. (2023 - 1999)

Historical Annual Inventory of Emmaus Life Sciences, Inc. (2023 - 1999)

Year	Inventory	Inventory Growth
2023	1.71 Million USD	-28.08%
2022	2.37 Million USD	-45.83%
2021	4.39 Million USD	-38.03%
2020	7.08 Million USD	-11.09%
2019	7.97 Million USD	69.42%
2018	4.7 Million USD	652.44%
2017	625.29 Thousand USD	276.21%
2016	166.2 Thousand USD	-24.16%
2015	219.16 Thousand USD	-12.48%
2014	250.41 Thousand USD	4.77%
2013	239 Thousand USD	446.93%
2012	43.7 Thousand USD	-39.39%
2011	72.1 Thousand USD	0.0%
2010	- USD	0.0%
2009	- USD	0.0%
2008	- USD	0.0%
2007	- USD	0.0%
2006	- USD	0.0%
2005	- USD	0.0%
2004	- USD	0.0%
2003	- USD	0.0%
2002	- USD	-100.0%
2001	253.00 USD	-78.49%
2000	1176.00 USD	-88.24%
1999	10 Thousand USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	1.62 Million USD	6.61%
2024 Q1	1.52 Million USD	-10.75%
2023 Q3	1.65 Million USD	-9.04%
2023 FY	1.71 Million USD	-28.08%
2023 Q1	2.21 Million USD	-6.85%
2023 Q2	1.81 Million USD	-18.14%
2023 Q4	1.71 Million USD	3.7%
2022 FY	2.37 Million USD	-45.83%
2022 Q2	3.13 Million USD	-9.24%
2022 Q1	3.45 Million USD	-21.38%
2022 Q3	2.73 Million USD	-12.6%
2022 Q4	2.37 Million USD	-13.14%
2021 Q2	6.54 Million USD	-2.92%
2021 FY	4.39 Million USD	-38.03%
2021 Q4	4.39 Million USD	-29.75%
2021 Q3	6.25 Million USD	-4.45%
2021 Q1	6.74 Million USD	-4.9%
2020 Q2	7.86 Million USD	-4.75%
2020 FY	7.08 Million USD	-11.09%
2020 Q1	8.25 Million USD	3.56%
2020 Q4	7.08 Million USD	-4.51%
2020 Q3	7.42 Million USD	-5.61%
2019 FY	7.97 Million USD	69.42%
2019 Q2	5.9 Million USD	1.92%
2019 Q3	7.49 Million USD	26.84%
2019 Q4	7.97 Million USD	6.41%
2019 Q1	5.79 Million USD	23.18%
2018 Q4	4.7 Million USD	40.55%
2018 Q3	3.34 Million USD	37.47%
2018 Q2	2.43 Million USD	141.45%
2018 Q1	1 Million USD	61.27%
2018 FY	4.7 Million USD	652.44%
2017 Q3	395.81 Thousand USD	46.16%
2017 FY	625.29 Thousand USD	276.21%
2017 Q4	625.29 Thousand USD	57.98%
2017 Q2	270.81 Thousand USD	3.59%
2017 Q1	261.42 Thousand USD	57.29%
2016 Q4	166.2 Thousand USD	-34.02%
2016 Q1	302.03 Thousand USD	37.81%
2016 FY	166.2 Thousand USD	-24.16%
2016 Q2	241.61 Thousand USD	-20.0%
2016 Q3	251.9 Thousand USD	4.26%
2015 Q3	294.58 Thousand USD	31.81%
2015 FY	219.16 Thousand USD	-12.48%
2015 Q4	219.16 Thousand USD	-25.6%
2015 Q2	223.48 Thousand USD	-16.57%
2015 Q1	267.88 Thousand USD	6.98%
2014 Q2	259.33 Thousand USD	2.53%
2014 Q1	252.93 Thousand USD	5.83%
2014 Q4	250.41 Thousand USD	11.9%
2014 FY	250.41 Thousand USD	4.77%
2014 Q3	223.78 Thousand USD	-13.71%
2013 FY	239 Thousand USD	446.93%
2013 Q1	109.6 Thousand USD	-46.11%
2013 Q4	239 Thousand USD	42.47%
2013 Q3	167.76 Thousand USD	62.25%
2013 Q2	103.4 Thousand USD	-5.66%
2012 FY	43.7 Thousand USD	-39.39%
2012 Q4	203.38 Thousand USD	-20.69%
2012 Q3	256.43 Thousand USD	0.0%
2012 Q2	- USD	0.0%
2012 Q1	- USD	-100.0%
2011 Q3	72.1 Thousand USD	7.45%
2011 Q1	- USD	0.0%
2011 FY	72.1 Thousand USD	0.0%
2011 Q2	67.1 Thousand USD	0.0%
2011 Q4	48.9 Thousand USD	-32.18%
2010 Q2	- USD	0.0%
2010 FY	- USD	0.0%
2010 Q4	- USD	0.0%
2010 Q1	- USD	0.0%
2010 Q3	- USD	0.0%
2009 Q1	- USD	0.0%
2009 FY	- USD	0.0%
2009 Q4	- USD	0.0%
2009 Q2	- USD	0.0%
2009 Q3	- USD	0.0%
2008 Q2	- USD	0.0%
2008 Q1	- USD	0.0%
2008 FY	- USD	0.0%
2008 Q4	- USD	0.0%
2008 Q3	- USD	0.0%
2007 Q2	- USD	0.0%
2007 Q1	- USD	0.0%
2007 FY	- USD	0.0%
2007 Q4	- USD	0.0%
2007 Q3	- USD	0.0%
2006 Q1	- USD	0.0%
2006 Q3	- USD	0.0%
2006 Q4	- USD	0.0%
2006 FY	- USD	0.0%
2006 Q2	- USD	0.0%
2005 Q4	- USD	0.0%
2005 Q1	- USD	0.0%
2005 Q2	- USD	0.0%
2005 FY	- USD	0.0%
2005 Q3	- USD	0.0%
2004 FY	- USD	0.0%
2004 Q4	- USD	0.0%
2004 Q2	- USD	0.0%
2004 Q1	- USD	0.0%
2004 Q3	- USD	0.0%
2003 Q1	- USD	0.0%
2003 Q2	- USD	0.0%
2003 Q3	- USD	0.0%
2003 Q4	- USD	0.0%
2003 FY	- USD	0.0%
2002 Q3	17.00 USD	-82.11%
2002 Q4	- USD	-100.0%
2002 Q2	95.00 USD	-36.24%
2002 Q1	149.00 USD	-41.11%
2002 FY	- USD	-100.0%
2001 Q1	835.00 USD	0.0%
2001 Q2	484.00 USD	-42.04%
2001 Q4	253.00 USD	-34.79%
2001 FY	253.00 USD	-78.49%
2001 Q3	388.00 USD	-19.83%
2000 FY	1176.00 USD	-88.24%
2000 Q1	10 Thousand USD	0.0%
2000 Q2	- USD	-100.0%
2000 Q3	- USD	0.0%
2000 Q4	- USD	0.0%
1999 Q2	10 Thousand USD	0.0%
1999 Q3	10 Thousand USD	0.0%
1999 Q4	10 Thousand USD	0.0%
1999 FY	10 Thousand USD	0.0%

Peer Inventory Comparison of Emmaus Life Sciences, Inc.

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	-9.961%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	-16506.814%
SQZ Biotechnologies Company	- USD	-Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	-0.825%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	20.455%
Mesoblast Limited	1.00 USD	-171099900.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	89.4 Million USD	98.086%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	1908.439%
Marizyme, Inc.	24.85 Thousand USD	-6783.927%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	-10593.75%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	-171099900.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	-118.24%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Neon Bloom, Inc.	7938.00 USD	-21454.548%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	96.986%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	-7479.516%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	-25.394%
IMV Inc.	2.00 USD	-85549900.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	-14158.333%
Curative Biotechnology, Inc.	-115.62 Thousand USD	1579.784%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	-1792.427%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	99.971%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	2.37 Million USD	27.836%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	-716.36%
argenx SE	310.55 Million USD	99.449%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	-14752.431%
Zenith Capital Corp.	3.00 USD	-57033233.333%
Genscript Biotech Corporation	53.33 Million USD	96.792%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	-3322.0%
WPD Pharmaceuticals Inc.	0.25 USD	-684399900.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	91.682%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	86.672%
Cotinga Pharmaceuticals Inc.	0.98 USD	-174591736.735%
BioStem Technologies, Inc.	658.67 Thousand USD	-159.763%
ONE Bio Corp.	4.5 Million USD	62.022%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	1.00 USD	-171099900.0%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	8377.297%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	19644187.256%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	1.26 Million USD	-35.471%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	88.593%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	1.00 USD	-171099900.0%
IntelGenx Technologies Corp.	71 Thousand USD	-2309.859%
Gelesis Holdings, Inc.	6.86 Million USD	75.076%
CSL Limited	5.96 Billion USD	99.971%
Cellectis S.A.	1.00 USD	-171099900.0%

Global Stocks Search

Emmaus Life Sciences, Inc. (EMMA)

Inventory Summary of Emmaus Life Sciences, Inc.

Annual Inventory Chart of Emmaus Life Sciences, Inc. (2023 - 1999)

Historical Annual Inventory of Emmaus Life Sciences, Inc. (2023 - 1999)

Peer Inventory Comparison of Emmaus Life Sciences, Inc.